Congo Red test GV-005
DeviceCongo Red test GV-005 test is a simple test has been developed to detect unfolded or misfolded proteins in urine.
NCT Number: NCT02610972
A case-control study will evaluate the clinical utility of the Congo Red test GV-005 in following women with a clinical diagnosis of preeclampsia and clinically healthy women in the postpartum period
Looking for future studies?
Notify Me18 year–64 year
Female
Observational
Dhaka Medical College, Dhaka, Bangladesh
A case-control study (n=150) will evaluate the clinical utility of the Congo Red test GV-005 in following women with a clinical diagnosis of preeclampsia and clinically healthy women in the postpartum period. Women with preeclampsia (n=100) (cases) and clinically healthy women (n=50)(controls) who are hospitalized postpartum will be recruited for the trial. All women will be asked to provide a urine sample. Samples will be collected daily during a woman's hospitalization. The Congo Red test GV-005 and a standard urine dipstick proteinuria test will be performed by a lab technician within 72 hours of sample collection. The purpose of this research is to evaluate progression of urine congophilia postpartum by following patients diagnosed with preeclampsia and clinically healthy women.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Congo Red test GV-005 test is a simple test has been developed to detect unfolded or misfolded proteins in urine.
Time frame: within 72 hours of urine sample collection
Prevalence of urine congophilia using Congo Red test GV-005
Gynuity Health Projects
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05802940
Aspirin, Behavior
Danville, Pennsylvania, United States
View Trial DetailsNCT07717931
Cardiovascular Diseases, Female Urogenital Diseases and Pregnancy Complications
Multan, Punjab Province, Pakistan
View Trial DetailsNCT07265336
Female Urogenital Diseases and Pregnancy Complications, Hypertension, Pregnancy-Induced
Panama City, Provincia de Panamá, Panama
View Trial DetailsNCT07040696
Acute Kidney Injury, Female Urogenital Diseases
Cairo, Giza Governorate, Egypt
View Trial Details